Pre-analytical stability of FGF23 with the contemporary immunoassays.
FGF23 immunoassays
Pre-analytical stability
Protease inhibitors
Journal
Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
30
01
2019
revised:
28
02
2019
accepted:
28
02
2019
pubmed:
4
3
2019
medline:
14
6
2019
entrez:
4
3
2019
Statut:
ppublish
Résumé
Several publications have reported on the pre-analytical stability of fibroblast growth factor 23 (FGF23) and some recommend coating blood collecting tubes with protease inhibitors, in order to prevent degradation. These recommendations are based on observations for a first generation assay for the measurement of intact FGF23. However, if this also applies for the contemporary immunoassays, and at what stage of pre-analysis, is unknown. We reviewed data from these previous reports on the issue of FGF23 stability and complemented these findings with data from novel experiments. We concluded that the contemporary intact FGF23 assays by Immutopics, Kainos, Millipore and DiaSorin do not suffer from immediate loss of FGF23 signal and do not require blood withdrawal in protease inhibitor-coated collecting tubes. Nevertheless, FGF23 concentrations do decline when centrifugation is delayed up to 8 h and prompt centrifugation is therefore advised.
Sections du résumé
BACKGROUND
BACKGROUND
Several publications have reported on the pre-analytical stability of fibroblast growth factor 23 (FGF23) and some recommend coating blood collecting tubes with protease inhibitors, in order to prevent degradation. These recommendations are based on observations for a first generation assay for the measurement of intact FGF23. However, if this also applies for the contemporary immunoassays, and at what stage of pre-analysis, is unknown.
METHODS
METHODS
We reviewed data from these previous reports on the issue of FGF23 stability and complemented these findings with data from novel experiments.
RESULTS
RESULTS
We concluded that the contemporary intact FGF23 assays by Immutopics, Kainos, Millipore and DiaSorin do not suffer from immediate loss of FGF23 signal and do not require blood withdrawal in protease inhibitor-coated collecting tubes. Nevertheless, FGF23 concentrations do decline when centrifugation is delayed up to 8 h and prompt centrifugation is therefore advised.
Identifiants
pubmed: 30826370
pii: S0009-8981(19)30094-4
doi: 10.1016/j.cca.2019.02.032
pii:
doi:
Substances chimiques
FGF23 protein, human
0
Fibroblast Growth Factors
62031-54-3
Fibroblast Growth Factor-23
7Q7P4S7RRE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104-106Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.